Drug application
CENTANY (MUPIROCIN)
Drugs@FDA NDA 050788 · PADAGIS US
Key facts
| Drug name | CENTANY |
|---|---|
| Active ingredients | MUPIROCIN |
| Application type | NDA |
| Application number | 050788 |
| Company | PADAGIS US |
| Dosage forms | OINTMENT, TOPICAL |
| Strength | 2% |
| Marketing status | Discontinued |
| TE codes | BX |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Dec 4, 2002 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: